Professional Overview
Tania Borg is a seasoned pharmaceutical professional currently serving as a Market Access Manager at Novartis, located in Birkirkara, Malta. Her key expertise areas include market access, government and public affairs, and regulatory affairs, with a strong industry focus on pharmaceuticals.
Experience Summary
Current Role
As the Market Access Manager at Novartis, Tania is responsible for developing and implementing market access strategies to ensure the successful launch and reimbursement of Novartis products. Her key responsibilities include stakeholder engagement, pricing and reimbursement negotiations, and market research. Notable achievements in this role are not specified, but her experience in government and public affairs has likely contributed to her success in this position.
Career Progression
Tania has had a notable career progression, starting as a Medical Representative at Novartis in 2007. She then moved to the role of Government & Public Affairs Officer in 2017, where she spent six years before being promoted to her current position as Market Access Manager. Prior to joining Novartis, Tania worked as a Senior Regulatory Affairs Officer at Teva/Actavis Generics from 2001 to 2006.
Areas of Expertise
Tania's areas of expertise include market access, government and public affairs, regulatory affairs, and pharmaceutical sales. She has demonstrated technical competencies in stakeholder engagement, pricing and reimbursement negotiations, and market research. Her leadership and management capabilities are evident in her career progression and current role.
Professional Impact
While specific notable projects or initiatives are not mentioned, Tania's career trajectory and growth suggest that she has made significant contributions to the pharmaceutical industry. Her experience in market access, government and public affairs, and regulatory affairs has likely had a positive impact on the industry.
Conclusion
Tania Borg is a highly experienced pharmaceutical professional with a strong background in market access, government and public affairs, and regulatory affairs. Her current focus as a Market Access Manager at Novartis is on developing and implementing market access strategies to ensure the successful launch and reimbursement of Novartis products. Her value proposition lies in her technical competencies, leadership and management capabilities, and industry expertise, making her a valuable asset to the pharmaceutical industry.